Ma XY - Search Results

Year	Number of Results
1980	1
1983	2
1985	1
1986	2
1988	4
1989	1
1990	2
1991	2
1992	3
1993	5
1994	5
1995	3
1996	3
1997	4
1998	1
2000	3
2001	6
2002	1
2003	5
2004	14
2005	11
2006	19
2007	11
2008	14
2009	16
2010	28
2011	38
2012	31
2013	52
2014	31
2015	37
2016	45
2017	41
2018	39
2019	57
2020	61
2021	71
2022	87
2023	107
2024	40

1

Multi-omics research in sarcopenia: Current progress and future prospects.

Liu JC, Dong SS, Shen H, Yang DY, Chen BB, Ma XY, Peng YR, Xiao HM, Deng HW. Liu JC, et al. Among authors: ma xy. Ageing Res Rev. 2022 Apr;76:101576. doi: 10.1016/j.arr.2022.101576. Epub 2022 Jan 29. Ageing Res Rev. 2022. PMID: 35104630 Review.

2

Stress-Induced Metabolic Disorder in Peripheral CD4⁺ T Cells Leads to Anxiety-like Behavior.

Fan KQ, Li YY, Wang HL, Mao XT, Guo JX, Wang F, Huang LJ, Li YN, Ma XY, Gao ZJ, Chen W, Qian DD, Xue WJ, Cao Q, Zhang L, Shen L, Zhang L, Tong C, Zhong JY, Lu W, Lu L, Ren KM, Zhong G, Wang Y, Tang M, Feng XH, Chai RJ, Jin J. Fan KQ, et al. Among authors: ma xy. Cell. 2019 Oct 31;179(4):864-879.e19. doi: 10.1016/j.cell.2019.10.001. Cell. 2019. PMID: 31675497 Free article.

3

Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer.

Liao L, Zhang YL, Deng L, Chen C, Ma XY, Andriani L, Yang SY, Hu SY, Zhang FL, Shao ZM, Li DQ. Liao L, et al. Among authors: ma xy. Cancer Res. 2023 Feb 3;83(3):471-484. doi: 10.1158/0008-5472.CAN-22-2709. Cancer Res. 2023. PMID: 36484700 Free PMC article.

4

Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli.

Sun J, Chen C, Cui CY, Zhang Y, Liu X, Cui ZH, Ma XY, Feng Y, Fang LX, Lian XL, Zhang RM, Tang YZ, Zhang KX, Liu HM, Zhuang ZH, Zhou SD, Lv JN, Du H, Huang B, Yu FY, Mathema B, Kreiswirth BN, Liao XP, Chen L, Liu YH. Sun J, et al. Among authors: ma xy. Nat Microbiol. 2019 Sep;4(9):1457-1464. doi: 10.1038/s41564-019-0496-4. Epub 2019 Jun 24. Nat Microbiol. 2019. PMID: 31235960 Free PMC article.

5

A bi-directional Mendelian randomization study of the sarcopenia-related traits and osteoporosis.

Ma XY, Liu HM, Lv WQ, Qiu C, Xiao HM, Deng HW. Ma XY, et al. Aging (Albany NY). 2022 Jul 2;14(14):5681-5698. doi: 10.18632/aging.204145. Epub 2022 Jul 2. Aging (Albany NY). 2022. PMID: 35780076 Free PMC article.

6

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.

Ji P, Gong Y, Jin ML, Wu HL, Guo LW, Pei YC, Chai WJ, Jiang YZ, Liu Y, Ma XY, Di GH, Hu X, Shao ZM. Ji P, et al. Among authors: ma xy. Sci Adv. 2022 Jul;8(26):eabl8247. doi: 10.1126/sciadv.abl8247. Epub 2022 Jun 29. Sci Adv. 2022. PMID: 35767614 Free PMC article.

7

CCL19⁺ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer.

Wu SY, Zhang SW, Ma D, Xiao Y, Liu Y, Chen L, Song XQ, Ma XY, Xu Y, Chai WJ, Jin X, Shao ZM, Jiang YZ. Wu SY, et al. Among authors: ma xy. Med. 2023 Jun 9;4(6):373-393.e8. doi: 10.1016/j.medj.2023.04.008. Epub 2023 May 17. Med. 2023. PMID: 37201522

8

Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer.

Zhou CB, Pan SY, Jin P, Deng JW, Xue JH, Ma XY, Xie YH, Cao H, Liu Q, Xie WF, Zou XP, Sheng JQ, Wang BM, Wang H, Ren JL, Liu SD, Sun YW, Meng XJ, Zhao G, Chen JX, Cui Y, Wang PQ, Guo HM, Yang L, Chen X, Ding J, Yang XN, Wang XK, Qian AH, Hou LD, Wang Z, Chen YX, Fang JY. Zhou CB, et al. Among authors: ma xy. Gastroenterology. 2022 Jun;162(7):1933-1947.e18. doi: 10.1053/j.gastro.2022.02.015. Epub 2022 Feb 12. Gastroenterology. 2022. PMID: 35167866

9

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.

Wu SY, Xu Y, Chen L, Fan L, Ma XY, Zhao S, Song XQ, Hu X, Yang WT, Chai WJ, Guo XM, Chen XZ, Xu YH, Zhu XY, Zou JJ, Wang ZH, Jiang YZ, Shao ZM. Wu SY, et al. Among authors: ma xy. Mol Cancer. 2022 Mar 25;21(1):84. doi: 10.1186/s12943-022-01536-6. Mol Cancer. 2022. PMID: 35337339 Free PMC article. Clinical Trial.

10

Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.

Zhang FL, Yang SY, Liao L, Zhang TM, Zhang YL, Hu SY, Deng L, Huang MY, Andriani L, Ma XY, Shao ZM, Li DQ. Zhang FL, et al. Among authors: ma xy. Theranostics. 2023 Jan 22;13(3):973-990. doi: 10.7150/thno.79688. eCollection 2023. Theranostics. 2023. PMID: 36793866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

832 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

832 results

Results by year